VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein

被引:19
作者
Brites, FD
Bonavita, CD
Cloës, M
Yael, MJ
Fruchart, JC
Castro, GR
Wikinski, RW
机构
[1] Univ Buenos Aires, Sch Pharm & Biochem, Dept Clin Biochem, Lab Lipids & Lipoprot, RA-1113 Buenos Aires, DF, Argentina
[2] Inst Pasteur, Serv Etud & Rech Lipoprot & Atherosclerose, INSERM, U325, F-59019 Lille, France
关键词
VLDL; HDL; hypertriglyceridemia; hypoalphalipoproteinemia; apolipoproteins C-III and E; CETP;
D O I
10.1016/S0009-8981(97)00193-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
VLDL chemical composition is related to plasma levels of triglycerides and HDL-cholesterol, We evaluated patients with primary hypertriglyceridemia with or. without hypoalphalipoproteinemia and subjects with normotriglyceridemia with hypoalphalipoproteinemia. The pattern observed in all the groups was an enrichment in the triglyceride content of VLDL and in apo B-VLDL. Compared to controls, LpC-III:B levels were higher in hypertriglyceridemic patients with low or normal HDL-cholesterol levels (7.3+/-0.6 vs. 14.9+/-1.8 and 12.3+/-2.8 mg/dl; P<0.005 and P<0.01, respectively) and LpE:B concentration was only increased in patients with hypertriglyceridemia and normal HDL-cholesterol levels (3.1+/-0.5 vs. 6.3+/-1.0 mg/dl; P < 0.01). The activity of the cholesteryl ester transfer protein was higher in hypertriglyceridemic patients with low HDL-cholesterol levels than in controls (380+/-25 vs. 262+/-14% cholesteryl esters/ml.h; P < 0.001). The most atypical VLDL particle was found in patients who combined an accumulation of VLDL particles and a reduction in HDL-cholesterol concentration. These two parameters represent both ends of the cholesteryl ester-triglyceride transfer, a crucial factor for VLDL chemical composition and HDL levels. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:107 / 124
页数:18
相关论文
共 43 条
  • [1] MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES
    AALTOSETALA, K
    FISHER, EA
    CHEN, XL
    CHAJEKSHAUL, T
    HAYEK, T
    ZECHNER, R
    WALSH, A
    RAMAKRISHNAN, R
    GINSBERG, HN
    BRESLOW, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1889 - 1900
  • [2] ALAUPOVIC P, 1982, RES CLIN LAB, V12, P3
  • [3] THE HYPERTRIGLYCERIDEMIAS - RISK AND MANAGEMENT - INTRODUCTION
    ASSMANN, G
    GOTTO, AM
    PAOLETTI, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (03) : A1 - A4
  • [4] High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
    Assmann, G
    Schulte, H
    vonEckardstein, A
    Huang, YD
    [J]. ATHEROSCLEROSIS, 1996, 124 : S11 - S20
  • [5] LDL-CHOLESTEROL DETERMINATION IN BLOOD-SERUM FOLLOWING PRECIPITATION OF LDL WITH POLYVINYLSULFATE
    ASSMANN, G
    JABS, HU
    KOHNERT, U
    NOLTE, W
    SCHRIEWER, H
    [J]. CLINICA CHIMICA ACTA, 1984, 140 (01) : 77 - 83
  • [6] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [7] PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART-DISEASE - THE EPIDEMIOLOGIC EVIDENCE AND BEYOND
    AUSTIN, MA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (02) : 249 - 259
  • [8] BARTLETT GR, 1959, J BIOL CHEM, V234, P466
  • [9] BLUM CB, 1982, J LIPID RES, V23, P1308
  • [10] BRADLEY WA, 1994, J INTERN MED, V236, P33